MarketBeat's profile
Blog
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
When the price of a high-quality stock such as AbbVie (NYSE: ABBV) declines after a report revealing growth, outperformance, and better-than-expected guidance, it's almost always a good time to
Pepsi Pops as Investors Take Notice of Key Strategic Initiatives
After activist investor Elliott Management announced a $4 billion investment in consumer staples giant PepsiCo (NASDAQ: PEP), the stock has gone on a solid run.
Elliott revealed its investment
With New CEOs, Is Walmart or Target the Better Buy Going Forward?
After gaining less than 4% in 2025 and finishing second-worst among the S&P 500’s 11 sectors, consumer staples stocks are staging a comeback this year.
Just over a month into 2026, the consumer
The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles
The first week of February 2026 will be remembered as the day the pharmaceutical sector’s most famous partnership officially dissolved. For years, Eli Lilly and Company (NYSE: LLY) and Novo
Analysts Love These 3 Stocks Trading Near 52-Week Lows—Here’s Why
Earnings season is kicking into high gear, and the common thread is that analysts and investors are looking for value. According to a Bank of America (NYSE: BAC) Credit Investor Survey, 30% of